August 6, 2013
Martha Jefferson Hospital is offering a new treatment for prostate cancer.
The hospital is the first in the region to offer Xofigo, which was recently approved by the Federal Drug Agency, and is used for men whose cancer has spread to their bones.
Doctors say the drug helps make treatment more bearable, and could allow patients to delay chemotherapy.
"This is a new avenue that we can treat patients with very little toxicity," says Dr. Sylvia Hendrix. "It’s been shown to improve survival and to reduce the pain the patients feel from the disease in their bones."
The drug is given by injection once a month for six months.